The present invention relates to novel isocyanate and isothiocyanate compounds, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans and animals. The novel isocyanate and isothiocyanate compounds are distinguished, as compared with the known isocyanate and isothiocyanate compounds, by improved therapeutical breadth, i.e. fewer side effects while having high anti-tumor activity.
本发明涉及新的
异氰酸酯和异
硫氰酸酯化合物,涉及包含它们的药物组合物,并涉及它们在人类和动物的癌症治疗中的应用。与已知的
异氰酸酯和异
硫氰酸酯化合物相比,这些新的
异氰酸酯和异
硫氰酸酯化合物通过改进的治疗广度,即在具有高抗肿瘤活性的同时减少副作用而得以区分。